Fresenius SE & Co. KGaA (FRE) News Today €33.20 -0.28 (-0.84%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma PortfolioDecember 17, 2024 | finance.yahoo.comOri Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene TherapiesDecember 11, 2024 | uk.finance.yahoo.comUBS Sticks to Their Buy Rating for Fresenius SE & Co. KGaA (0OO9)November 26, 2024 | markets.businessinsider.comKepler Capital Sticks to Its Buy Rating for Fresenius SE & Co. KGaA (0OO9)November 8, 2024 | markets.businessinsider.comDeutsche Bank Keeps Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)November 7, 2024 | markets.businessinsider.comJ.P. Morgan Remains a Buy on Fresenius SE & Co. KGaA (0OO9)November 7, 2024 | markets.businessinsider.comFresenius SE & Co KGaA (FSNUF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...November 7, 2024 | finance.yahoo.comProfit surges in third quarter for Germany's Fresenius Medical CareNovember 5, 2024 | msn.comGermany shares lower at close of trade; DAX down 1.03%November 1, 2024 | msn.comGermany shares higher at close of trade; DAX up 0.34%October 29, 2024 | msn.comGermany stocks lower at close of trade; DAX down 1.02%October 21, 2024 | msn.comFresenius SE & Co KGaA (FSNUF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...October 9, 2024 | finance.yahoo.comWhile institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE), individual investors are its largest shareholders with 43% ownershipOctober 7, 2024 | finance.yahoo.comGermany shares lower at close of trade; DAX down 0.68%September 30, 2024 | msn.comGlenview set to meet CVS Health top executives to drive changes - reportSeptember 30, 2024 | seekingalpha.comPositive Report for Fresenius SE & Co. KGaA (0OO9) from J.P. MorganSeptember 13, 2024 | markets.businessinsider.comLocal Anesthesia Drugs Market Report 2024: Key Players, Trends, and Forecasts to 2030August 29, 2024 | uk.finance.yahoo.comFresenius SE & Co KGaA (FREA.MU)August 22, 2024 | nz.finance.yahoo.comGlobal Transfusion Technology Market Size To Worth USD 53.9 Billion By 2033 | CAGR Of 14.11%August 15, 2024 | finance.yahoo.comJefferies Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)August 9, 2024 | markets.businessinsider.comFresenius SE & Co KGaA (FREA.BE)August 3, 2024 | finance.yahoo.comBerenberg Bank Reaffirms Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)August 1, 2024 | markets.businessinsider.comGoldman Sachs Keeps Their Hold Rating on Fresenius SE & Co. KGaA (0OO9)August 1, 2024 | markets.businessinsider.comFresenius beats Q2 expectations on strong unit performance, cost savingsJuly 31, 2024 | reuters.comFresenius Medical’s Cost Cuts Help Results Beat EstimatesJuly 30, 2024 | bloomberg.comDeutsche Numis Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)July 19, 2024 | markets.businessinsider.comCompare with FTSE Fresenius SE & Co KGaA Index (SSFREG)May 27, 2024 | msn.comInvestors five-year losses continue as Fresenius SE KGaA (ETR:FRE) dips a further 3.8% this week, earnings continue to declineMay 23, 2024 | finance.yahoo.comFresenius Shares Rise After Guidance Lift, Vamed ExitMay 8, 2024 | marketwatch.comEQS-News: STRABAG expands service portfolio in technical facility management with acquisition of parts of VAMEDMay 7, 2024 | markets.businessinsider.comFresenius Said to Plan Elimination of Vamed in Streamlining StepMay 7, 2024 | bloomberg.comFresenius to Sell Vamed's Rehabilitation Business to PAI PartnersMay 2, 2024 | marketwatch.comFresenius Sells Controlling Stake in Vamed Rehab Business to PAIMay 2, 2024 | bloomberg.comInstitutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the companyApril 30, 2024 | finance.yahoo.comGlobal Drug Infusion System Market Size Grows Steadily at a CAGR of 6.9%: Straits ResearchApril 29, 2024 | finance.yahoo.comApheresis Market Worth $3.9 billion | MarketsandMarketsApril 13, 2024 | finanznachrichten.deGlobal Local Anesthesia Drugs Market Forecast Reveals High Demand and Expansion by 2029March 27, 2024 | uk.finance.yahoo.comFresenius SE & Co. KGaAFebruary 29, 2024 | barrons.comFresenius SE: Hoping For The Turnaround In 2024February 28, 2024 | seekingalpha.comU.S. Futures Fall, European Stocks MixedFebruary 22, 2024 | marketwatch.comHealthcare group Fresenius tops Q4 operating profit forecastFebruary 21, 2024 | msn.comFresenius 4Q Rev EUR5.68BFebruary 21, 2024 | marketwatch.comHealthcare group Fresenius tops Q4 operating profit expectationsFebruary 21, 2024 | msn.comFresenius Medical Care delivers on commitments in a year of fundamental transformationFebruary 20, 2024 | finanznachrichten.deFresenius SE & Co. KGaA (FRE.DE)February 20, 2024 | finance.yahoo.comA Preview Of Fresenius Medical Care's EarningsFebruary 19, 2024 | benzinga.comAutotransfusion Devices Market revenue to surpass USD 400 Million by 2033, says Research NesterFebruary 6, 2024 | finance.yahoo.comCVS Health Q4 earnings on deck for early WednesdayFebruary 6, 2024 | msn.comFresenius SE & Co KGaAFebruary 4, 2024 | morningstar.comCigna beats top-line and bottom-line estimates; raises FY 2024 EPS outlook and raises dividendFebruary 2, 2024 | msn.com Get Fresenius SE & Co. KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for FRE and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now FRE Media Mentions By Week FRE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FRE News Sentiment▼0.000.60▲Average Medical News Sentiment FRE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FRE Articles This Week▼11▲FRE Articles Average Week Get Fresenius SE & Co. KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for FRE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fresenius Medical Care News Fielmann Group News Genfit News Sanofi News Sartorius Stedim Biotech News Siemens Healthineers News Bayer Aktiengesellschaft News Merck KGaA News Carl Zeiss Meditec News Gerresheimer News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (FRA:FRE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius SE & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius SE & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
